Abstract
Copy number variation (CNV) has been associated increasingly with altered susceptibility to human disease. Large CNVs are likely to incur disease risk or resilience via predictable changes in gene dosage that are relatively straightforward to model using chromosomal engineering in mice. The classical class I major histocompatibility locus (MHC-I) contains a dense set of genes essential for innate immune system function in vertebrates. MHC-I genes are highly polymorphic and genetic variation in the region is associated with altered susceptibility to a wide variety of common diseases. Here we investigated the role of gene dosage within MHC-I on susceptibility to disease by engineering a mouse line carrying a 1.9-Mb duplication of this region [called Dp(MHC-I)]. Extensive phenotypic analysis of heterozygous (3N) Dp(MHC-I) animals did not reveal altered blood and stem cell parameters, susceptibility to high-fat diet, death by cancer, or contact dermatitis. However, several measures of disease severity in a model of atherosclerosis were improved, suggesting dosage-sensitive modulators of cardiovascular disease. Homozygous Dp(MHC-I)/Dp(MHC-I) mice demonstrated embryonic lethality. These mice serve as a model for studying the consequences of targeted gene dosage alteration in MHC-I with functional and evolutionary implications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams DJ, Biggs PJ et al (2004) Mutagenic insertion and chromosome engineering resource (MICER). Nat Genet 36(8):867–871
Akashi K, Traver D et al (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404(6774):193–197
Apanius V, Penn D et al (1997) The nature of selection on the major histocompatibility complex. Crit Rev Immunol 17(2):179–224
Asano K, Matsushita T et al (2009) A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet 41(12):1325–1329
Bagchi A, Papazoglu C et al (2007) CHD5 is a tumor suppressor at human 1p36. Cell 128(3):459–475
Beckmann JS, Estivill X et al (2007) Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet 8(8):639–646
Beckmann JS, Sharp AJ et al (2008) CNVs and genetic medicine (excitement and consequences of a rediscovery). Cytogenet Genome Res 123(1–4):7–16
Besson V, Brault V et al (2007) Modeling the monosomy for the telomeric part of human chromosome 21 reveals haploinsufficient genes modulating the inflammatory and airway responses. Hum Mol Genet 16(17):2040–2052
Chaignat E, Yahya-Graison EA et al (2011) Copy number variation modifies expression time courses. Genome Res 21(1):106–113
Christensen AD, Haase C (2012) Immunological mechanisms of contact hypersensitivity in mice. APMIS 120(1):1–27
Davies RW, Wells GA et al (2012) A genome wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet 5(2):217–225
Dawkins R, Leelayuwat C et al (1999) Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev 167:275–304
Degenhardt Y, Huang J et al (2010) Distinct MHC gene expression patterns during progression of melanoma. Genes Chromosomes Cancer 49(2):144–154
Ermakova O, Piszczek L et al (2011) Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice. EMBO Mol Med 3(1):50–66
Henrichsen CN, Vinckenbosch N et al (2009) Segmental copy number variation shapes tissue transcriptomes. Nat Genet 41(4):424–429
Horton R, Wilming L et al (2004) Gene map of the extended human MHC. Nat Rev Genet 5(12):889–899
Itsara A, Cooper GM et al (2009) Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet 84(2):148–161
Jiang M, Li M et al (2008) Simultaneous detection of genomic and expression alterations in prostate cancer using cDNA microarray. Prostate 68(14):1496–1509
Koolen DA, Vissers LE et al (2006) A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 38(9):999–1001
Kubler K, Arndt PF et al (2008) Genetic alterations of HLA-class II in ovarian cancer. Int J Cancer 123(6):1350–1356
Kulski JK, Shiina T et al (2002) Comparative genomic analysis of the MHC: the evolution of class I duplication blocks, diversity and complexity from shark to man. Immunol Rev 190:95–122
Liu P, Zhang H et al (1998) Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. Genetics 150(3):1155–1168
Lutgens E, de Muinck D et al (2001) Compensatory enlargement and stenosis develop in apoE(−/−) and apoE*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol 21(8):1359–1365
Moser AR, Dove WF et al (1992) The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 116(6):1517–1526
Nakatani J, Tamada K et al (2009) Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 137(7):1235–1246
Ni M, Zhang M et al (2008) Micro-ultrasound imaging assessment of carotid plaque characteristics in apolipoprotein-E knockout mice. Atherosclerosis 197(1):64–71
Nichols J, Zevnik B et al (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95(3):379–391
Niwa H, Miyazaki J et al (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24(4):372–376
Orozco LD, Cokus SJ et al (2009) Copy number variation influences gene expression and metabolic traits in mice. Hum Mol Genet 18(21):4118–4129
Prugnolle F, Manica A et al (2005) Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 15(11):1022–1027
Ramirez-Solis R, Liu P et al (1995) Chromosome engineering in mice. Nature 378(6558):720–724
Redon R, Ishikawa S et al (2006) Global variation in copy number in the human genome. Nature 444(7118):444–454
Redshaw Z, Strain AJ (2010) Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression. J Negat Results Biomed 9(1):2
Rioux JD, Goyette P et al (2009) Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci USA 106(44):18680–18685
Santos J, Herranz M et al (1998) A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4. Oncogene 17(7):925–929
Seo HS, Lombardi DM et al (1997) Peripheral vascular stenosis in apolipoprotein E-deficient mice. Potential roles of lipid deposition, medial atrophy, and adventitial inflammation. Arterioscler Thromb Vasc Biol 17(12):3593–3601
Solberg LC, Valdar W et al (2006) A protocol for high-throughput phenotyping, suitable for quantitative trait analysis in mice. Mamm Genome 17(2):129–146
Stefansson H, Ophoff RA et al (2009) Common variants conferring risk of schizophrenia. Nature 460(7256):744–747
Stranger BE, Forrest MS et al (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315(5813):848–853
Stylianou IM, Bauer RC et al (2012) Genetic basis of atherosclerosis: insights from mice and humans. Circ Res 110(2):337–355
Tai MH, Chang CC et al (2005) Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26(2):495–502
Taylor KE, Criswell LA (2009) Conditional analysis of the major histocompatibility complex in rheumatoid arthritis. BMC Proc 3(Suppl 7):S36
Walker M 3rd, Campbell BR et al (2009) A novel 3-dimensional micro-ultrasound approach to automated measurement of carotid arterial plaque volume as a biomarker for experimental atherosclerosis. Atherosclerosis 204(1):55–65
Walz K, Caratini-Rivera S et al (2003) Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance. Mol Cell Biol 23(10):3646–3655
Wikström J, Grönros J et al (2005) Functional and morphologic imaging of coronary atherosclerosis in living mice using high-resolution color Doppler echocardiography and ultrasound biomicroscopy. J Am Coll Cardiol 46(4):720–727
Yu T, Li Z et al (2010) A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet 19(14):2780–2791
Zhang SH, Reddick RL et al (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258(5081):468–471
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ermakova, O., Salimova, E., Piszczek, L. et al. Construction and phenotypic analysis of mice carrying a duplication of the major histocompatibility class I (MHC-I) locus. Mamm Genome 23, 443–453 (2012). https://doi.org/10.1007/s00335-012-9401-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-012-9401-7